Alisha & Brett navigating scalp psoriasis

NARRATOR (VO):  
We invited one dermatologist and four patients to speak openly about psoriasis. 

 On-screen Text:  
Dr. Ackerman is a paid consultant for AbbVie. 

 On-screen Text:  
Patients were on prescribed SKYRIZI (risankizumab-rzaa) therapy at the time of providing a testimonial. Changes in therapy may have occurred since that time. Individual results may vary. 

 On-screen Text:
 ALISHA & BRETT  
Diagnosed with moderate to severe plaque psoriasis, including scalp psoriasis 

 On-screen Text: 
ALISHA & BRETT  
NAVIGATING SCALP PSORIASIS  

WILL (VO):  
Did you experience psoriasis symptoms in any hard-to-treat areas and what was that like? 

 BRETT (VO):  
When psoriasis hit, it started in my scalp. I couldn’t get my skin clear enough. The raised, redness and scalp flaking. It was awful. 

 ALISHA (VO):  
Yeah, my scalp was really, hard to treat.  

 ALISHA (VO):  
It’s like I have this kinky, coily hair, and a lot of treatments you can’t put in your hair.  

 On-screen Text: 
SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy). 

 ALISHA (VO):  
And I just remember my grandmother having to take all day long to wash it and condition it.  

 On-screen Text: 
Please keep watching for Important Safety Information. 

 ALISHA (VO):  
You’re always having to think two steps ahead in regards to how is my psoriasis going to show itself to those around me. 

BRETT (VO):  
It was constantly on your mind. 

BRETT (VO):
I would go into my office, and I would just sit there and do this trying to get as much of it off of me as I could, so that I wouldn’t be presenting and feel like stuff’s just falling off. 

SELINA (VO): 
Walk us through your story about how you chose a biologic for your plaque psoriasis. 

 BRETT (VO):  
I was covered in plaques, and when I looked at Dr. Ackerman, I think I was probably crying at the time, and I just said I gotta get rid of this. 

 On-screen Text: 
Brett and his doctor discussed the side effects, risks, and safety profile of SKYRIZI.  

BRETT (VO): 
Topicals and shampoos were not working for me. 

 BRETT (VO): 
And she went to SKYRIZI. That’s the one I’ve been on since. 

 ALISHA (VO):  
Yeah, for me, topicals and phototherapies just weren’t doing enough. 

 On-screen Text: 
Alisha and her doctor discussed the side effects, risks, and safety profile of SKYRIZI.  

 ALISHA (VO): 
And so, I went to talk to my dermatologist and she suggested SKYRIZI. 

BRETT (VO):  
How did your skin improve with SKYRIZI?  

On-screen Text: 
In a study of 105 patients with moderate to severe scalp psoriasis, a majority of patients on SKYRIZI achieved clearer skin on their scalp at 4 months.  

BRETT (VO):  
Well, it started to clear up, I didn’t have the red plaques 

 ALISHA (VO):  
Those plaques started to fade. And then over time, they went away. 

 On-screen Text: 
In the same study, many patients on SKYRIZI were 100% plaque free on their scalp at 4 months. 

 BRETT (VO):  
My skin being clearer is probably the greatest thing.  

 BRETT (VO): 
...In my role of presenting to large groups of people to feel like, okay, they’re looking at me and listening to me. It was nice. 

 On-screen Text: 
Please keep watching for Important Safety Information. 

 V.O./On-screen Text:     
IMPORTANT SAFETY INFORMATION AND USE  

SKYRIZI® (risankizumab-rzaa) USE  
SKYRIZI is a prescription medicine used to treat adults with moderate to severe plaque psoriasis who may benefit from taking injections or pills (systemic therapy) or treatment using ultraviolet or UV light (phototherapy).

 Important Safety Information   

What is the most important information I should know about SKYRIZI® (risankizumab-rzaa)?  

SKYRIZI is a prescription medicine that may cause serious side effects, including: 

Serious allergic reactions:  

Stop using SKYRIZI and get emergency medical help right away if you get any of the following symptoms of a serious allergic reaction:  

  • fainting, dizziness, feeling lightheaded (low blood pressure)
  • swelling of your face, eyelids, lips, mouth, tongue, or throat  
  • trouble breathing or throat tightness  
  • chest tightness  
  • skin rash, hives
  • itching  

Infections:  
SKYRIZI may lower the ability of your immune system to fight infections and may increase your risk of infections. Your healthcare provider should check you for infections and tuberculosis (TB) before starting treatment with SKYRIZI and may treat you for TB before you begin treatment with SKYRIZI if you have a history of TB or have active TB. Your healthcare provider should watch you closely for signs and symptoms of TB during and after treatment with SKYRIZI.  

  • Tell your healthcare provider right away if you have an infection or have symptoms of an infection, including:  
  • fever, sweats, or chills  
  • cough  
  • shortness of breath  
  • blood in your mucus (phlegm)  
  • muscle aches  
  • warm, red, or painful skin or sores on your body different from your psoriasis  
  • weight loss  
  • diarrhea or stomach pain  
  • burning when you urinate or urinating more often than normal  

Do not use SKYRIZI if you are allergic to risankizumab-rzaa or any of the ingredients in SKYRIZI. See the Medication Guide or Consumer Brief Summary for a complete list of ingredients. 

Before using SKYRIZI, tell your healthcare provider about all of your medical conditions, including if you:  

  • have any of the conditions or symptoms listed in the section “What is the most important information I should know about SKYRIZI?”  
  • have an infection that does not go away or that keeps coming back.  
  • have TB or have been in close contact with someone with TB.  
  • have recently received or are scheduled to receive an immunization (vaccine). Medications that interact with the immune system may increase your risk of getting an infection after receiving live vaccines. You should avoid receiving live vaccines right before, during, or right after treatment with SKYRIZI. Tell your healthcare provider that you are taking SKYRIZI before receiving a vaccine.  
  • are pregnant or plan to become pregnant. It is not known if SKYRIZI can harm your unborn baby.  
  • are breastfeeding or plan to breastfeed. It is not known if SKYRIZI passes into your breast milk.  
  • become pregnant while taking SKYRIZI. You are encouraged to enroll in the Pregnancy Registry, which is used to collect information about the health of you and your baby. Talk to your healthcare provider or call 1-877-302-2161 to enroll in this registry.  

Tell your healthcare provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.  

 What are the possible side effects of SKYRIZI?
SKYRIZI may cause serious side effects. See “What is the most important information I should know about SKYRIZI?”  

The most common side effects of SKYRIZI in people treated for plaque psoriasis and psoriatic arthritis  include: upper respiratory infections, headache, feeling tired, injection site reactions, and fungal skin infections.  

These are not all the possible side effects of SKYRIZI. Call your doctor for medical advice about side effects.  

Use SKYRIZI exactly as your healthcare provider tells you to use it.  

SKYRIZI is available in a 150 mg/mL prefilled syringe and pen.  

Please see the Full Prescribing Information, including the Medication Guide, for SKYRIZI.  

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda/gov/medwatch or call 1-800-FDA-1088.  

If you are having difficulty paying for your medicine, AbbVie may be able to help. Visit AbbVie.com/PatientAccessSupport to learn more.  

© 2025 AbbVie. All rights reserved. SKYRIZI® and its design are registered trademarks of AbbVie Biotechnology Ltd.  

US-SKZD-250234